Previous Article | Next Article 
J Virol, January 1998, p. 133-141, Vol. 72, No. 1
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Fusion Activity of Transmembrane and Cytoplasmic
Domain Chimeras of the Influenza Virus Glycoprotein
Hemagglutinin
Britta
Schroth-Diez,1
Evgeni
Ponimaskin,2
Helmut
Reverey,2
Michael F. G.
Schmidt,2 and
Andreas
Herrmann1,*
Institut für Biologie/Biophysik,
Mathematisch-Naturwissenschaftliche Fakultät I,
Humboldt-Universität zu Berlin, D-10115
Berlin,1 and
the Institut für
Immunologie und Molekularbiologie, Fachbereich
Veterinärmedizin der Freien Universität Berlin, D-10117
Berlin,2 Germany
Received 19 May 1997/Accepted 23 September 1997
 |
ABSTRACT |
The role of the sequence of transmembrane and
cytoplasmic/intraviral domains of influenza virus hemagglutinin (HA,
subtype H7) for HA-mediated membrane fusion was explored. To analyze
the influence of the two domains on the fusogenic properties of HA, we
designed HA-chimeras in which the cytoplasmic tail and/or transmembrane domain of HA was replaced with the corresponding domains of the fusogenic glycoprotein F of Sendai virus. These chimeras, as well as
constructs of HA in which the cytoplasmic tail was replaced by peptides
of human neurofibromin type1 (NF1) or c-Raf-1, NF78 (residues 1441 to
1518), and Raf81 (residues 51 to 131), respectively, were expressed in
CV-1 cells by using the vaccinia virus-T7 polymerase transient-expression system. Wild-type and chimeric HA were cleaved properly into two subunits and expressed as trimers. Membrane fusion
between CV-1 cells and bound human erythrocytes (RBCs) mediated by
parental or chimeric HA proteins was studied by a lipid-mixing assay
with the lipid-like fluorophore octadecyl rhodamine B chloride (R18).
No profound differences in either extent or kinetics could be observed.
After the pH was lowered, the above proteins also induced a flow of the
aqueous fluorophore calcein from preloaded RBCs into the cytoplasm of
the protein-expressing CV-1 cells, indicating that membrane fusion
involves both leaflets of the lipid bilayers and leads to formation of
an aqueous fusion pore. We conclude that neither HA-specific sequences
in the transmembrane and cytoplasmic domains nor their length is
crucial for HA-induced membrane fusion activity.
 |
INTRODUCTION |
Fusion of influenza virus with its
target membrane is mediated by the viral envelope protein HA at low pH.
Acidification converts the HA into a fusogenic conformation, thereby
exposing the hydrophobic N terminus of the HA2 subunit (36).
This fusion peptide, which is highly conserved among different
influenza virus strains, is believed to interact with the target
membrane, where it causes a transient destabilization of the lipid
bilayer (33). While the relevance of this peptide for fusion
has been well documented, the role of other HA sequences in fusion is
less established. Recent investigations emphasize the relevance of the
membrane-spanning (15) and cytoplasmic (12, 32)
domains of HA for the formation of a fusion pore and virus infectivity.
Replacement of the TMR by a GPI anchor suppressed the formation of an
aqueous pore between HA-expressing cells and RBC ghosts, while membrane
(hemi)-fusion was not inhibited (15, 17, 19, 25).
Furthermore, deletion of the CT of HA has been suggested to affect
fusion kinetics (12) and shown to modulate virus infectivity
(14, 32). Thus, while the interaction of the fusion sequence
with the adjacent membrane is sufficient to trigger membrane fusion,
the TMR and possibly the CT are essential principally for formation and
widening of the aqueous fusion pore.
It has been shown for several other enveloped viruses that modification
of the membrane-spanning domain and the CT of the glycoprotein may
affect fusion activity. Alterations of the TMR of the gp41 envelope
glycoprotein of human immunodeficiency virus by various point mutations
(10, 26) or its substitution by the respective domain of
vesicular stomatitis virus G protein (26) decreased or
abolished cell fusion. Truncation of the cytoplasmic sequence of gp41
blocked the fusion activity (26) and infectivity (7) of virus. Specific truncation of the cytoplasmic domain of the virus envelope protein of simian immunodeficiency virus enhanced
(3, 29) or diminished (34) syncytium formation. Truncation of the COOH-terminal region (i.e., the CT) of the fusion protein F of paramyxovirus SV5 led to a decrease of cytoplasmic content
mixing activity, which correlated with the extent of the deletion
(2). However, modification of those domains does not necessarily affect fusion activity. For example, while deletion of the
entire cytoplasmic domain of the fusion protein of human parainfluenza
virus type 3 did eliminate cell fusion activity (37), it was
not impaired in a mutant of human parainfluenza virus type 2 with a
truncated CT (37).
Whether for influenza virus HA the presence of any transmembrane and
cytoplasmic domains per se is sufficient to trigger the formation of an
aqueous fusion pore or whether the specific HA sequences are required
for complete fusion has not been addressed systematically. Earlier
studies suggested that the parallel replacement of both domains of the
wt HA by related domains of another enveloped virus fusion protein does
not inhibit fusion activity (6, 30). However, those studies
left open whether both domains form a functional entity and whether the
replacement of only one domain would affect fusion. Moreover, it
remains to be elucidated whether the kinetics of fusion mediated by
chimeric constructs with changed transmembrane and/or cytoplasmic
domains were altered. Here, we addressed these questions by
investigating the fusogenic ability of various chimeric HA. In one set
of chimeras, the CT and/or TMR of HA (subtype H7) was substituted by
the corresponding domains of the glycoprotein F of Sendai virus.
Glycoprotein F has been shown to be responsible for triggering fusion
between Sendai virus and its target (reviewed in reference
26). HA and F differ significantly in their amino acid sequence of both domains as well as in the length of their CT,
with about 42 aa for F and 10 aa for HA. In two other constructs, we
replaced the cytoplasmic domain of HA by large peptides of the human
neurofibromin type 1 (NF1; ras regulator) or c-Raf-1 (ras effector), NF78 (residues 1441 to 1518; 78 aa), and
Raf81 (residues 51 to 131; 81 aa), respectively. Both fragments
(8, 23) are derived from cytoplasm-soluble proteins and
differ from the HA or F CT in amino acid sequence, peptide length, and
function. Thus, if specific sequences of the C terminus of HA were
required for fusion, we would expect significant effects on the
fusogenic properties, in particular of the last two chimeric
constructs.
We expressed wt HA and the various chimeric protein constructs in
monkey kidney cells (CV-1) by using the vaccinia virus-T7 polymerase
transient-expression system (1, 9, 28). This transient-expression system allowed us to efficiently screen chimeras for differences in their low-pH-induced fusion activity with RBCs as
targets. By fluorescence microscopy and spectroscopy, both membrane
mixing and the formation of an aqueous fusion pore were assessed by
double labeling of RBCs with appropriate fluorophores, the lipid analog
R18, and the water-soluble fluorophore calcein. Our results show that
neither sequence specificity nor a certain length of the CT is required
for HA to induce membrane fusion or pore formation.
 |
MATERIALS AND METHODS |
Abbreviations used in this paper.
aa, amino acids; BSA,
bovine serum albumin; CT, cytoplasmic tail; DMEM, Dulbecco's modified
Eagle's medium; DMEM+, DMEM supplemented with 5% FCS; DMEM
, DMEM
without FCS; DMEM/met
, methionine-deficient DMEM; FACS,
fluorescence-activated cell sorter; FCS, fetal calf serum; FDQ,
fluorescence dequenching; GPI, glycosylphosphatidylinositol; HA,
influenza virus hemagglutinin; PBS, phosphate-buffered saline; PBS++,
PBS containing 1 mM CaCl2 and 1 mM MgCl2; RBC,
human erythrocytes; R18, octadecyl rhodamine B chloride; SDS-PAGE,
sodium dodecyl sulfate-polyacrylamide gel electrophoresis; TMR,
transmembrane region; WGA, wheat germ agglutinin; wt, wild type.
Materials.
The fluorophores R18 and calcein-AM were
purchased from Molecular Probes; and Tran[35S]-label
(>1,000 Ci/mmol) was purchased from ICN Radiochemicals. The enzymes
used in molecular cloning were obtained from New England Biolabs. DMEM,
trypsin versene, and FCS were purchased from BioWhittaker; DMEM without
L-methionine and L-glutamine,
L-glutamine, 2YT medium, and Lipofectin reagent were
purchased from Life Technologies Inc.; protein A-Sepharose beads were
purchased from Pharmacia Biotech. AmpliTaq DNA polymerase was obtained
from Perkin-Elmer. The ExSite PCR-based site-directed mutagenesis kit
was purchased from Stratagene; the Sculptor in vitro mutagenesis system
was purchased from Amersham. Oligonucleotide primers used for
sequencing and PCR were synthesized by Pharmacia Biotech and Gibco BRL.
Neuraminidase (VCNA from Vibrio cholerae) was obtained from
Behringwerke AG, trypsin-EDTA solution (0.05% trypsin and 0.02% EDTA
in PBS) was purchased from Biochrome KG, and secondary antibody was
purchased from Dakopatts. Cell culture dishes were purchased from Nunc
(Biochrome KG).
Recombinant DNA procedures.
All basic DNA procedures were
done as described by Sambrook et al. (31). For transient
expression in CV-1 cells, the F wt cDNA and the HA wt (subtype H7) cDNA
were subcloned into the EcoRI site in the polylinker of the
pTM1 vector (22), resulting in pTM/F and pTM/HA,
respectively.
The H/HF/F chimera (see Table 1) was created by removing the sequence
between the NdeI site at bp 1670 of the HA gene (followed by
treatment with Klenow fragment) and the XhoI site at a
polylinker downstream of the HA gene in pTM/HA. The fragment of the F
cDNA encoding the C-terminal 54 aa isolated after digestion of pTM/F with SspI and XhoI was then subcloned into the
above construct. The H/H/F chimera was made from H/HF/F with the ExSite
PCR-based site-directed mutagenesis kit (Stratagene) as specified by
the manufacturer. The mutagenesis sense PCR primer was 5'-TAT AGA CTC
AGA AGG TGT ATG CTA ATG TGT AAT C-3', and the antisense primer was
5'-CAC TAT AAT GAA CAC CAA GCC CAT TGC-3'.
The H/F/F and H/F/H chimeras (see Table 1) were produced by standard
PCR protocols and the overlap extension technique (11). The
internal sense PCR primers were 5'-GTG GCT ACA AAG ATG TGA TTA CGA TCA
TAG TAG-3' (H/F/F) or 5'-ATC ATC GTG CTT AAG AAC GGA AAC ATG CGG-3'
(H/F/H), and the antisense primers were 5'-TGA TCG TAA TCA CAT CTT TGT
AGC CAC TAC TC-3' (H/F/F) or 5'-GTT TCC GTT CTT AAG CAC GAT GAT GAT CAC
T-3' (H/F/H). The external PCR sense and antisense primers were 5'-ATG
AAC ACT CAA ATC CTG GTT TTC-3' and 5'-TTA GGC CTC TCG AGC TGC AG-3',
respectively. The H/H/N and H/H/R chimeras were constructed by PCR as
described recently (24). The primary sequence of all mutants
and chimeras was verified by double-stranded DNA sequencing at the
level of the final plasmid.
Cell culture and vaccinia virus-based expression of foreign
genes.
CV-1 cells were maintained as monolayer cultures in DMEM+.
Transient expression of HA as well as the chimeric proteins in CV-1
cells was performed as described previously by Fuerst et al.
(9). Subconfluent monolayers of cells grown on
35-mm-diameter plastic dishes were infected with recombinant vaccinia
virus vTF7-3 (9), which expresses T7 RNA polymerase, at a
multiplicity of infection of 10 PFU per cell and incubated at 37°C
for 60 min. The virus inoculum was removed, and the cells were washed
once with DMEM
and transfected with 3 µg of the respective
plasmid DNA, using Lipofectin as the transfecting agent as described by the manufacturer. At 4 h posttransfection, the cells were washed again with DMEM
and further treated for metabolic labeling, FACS analysis, or fusion assays.
Isotopic labeling of polypeptides, immunoprecipitation, and
SDS-PAGE.
Cells expressing the recombinant glycoproteins were
incubated in DMEM/met
for 30 min at 4 h posttransfection and
labeled with 50 µCi of Tran[35S]-label in 600 µl of
DMEM/met
. After 3 h, the cells were washed once with cold PBS
and lysed in ice-cold RIPA buffer (0.15 M NaCl and 20 mM Tris-HCl [pH
7.4] containing 1% Triton X-100, 1% sodium deoxycholate, 0.1% SDS,
1 mM phenylmethylsulfonyl fluoride, and 10 mM iodoacetamide). Lysates
were centrifuged at 14,000 × g for 5 min, and the
resulting supernatants were immunoprecipitated overnight at 4°C with
polyclonal antibodies directed against influenza A virus (subtype H7).
Immunoprecipitates were analyzed by SDS-PAGE on 12% acrylamide gels
and visualized by fluorography (1 day) with Kodak X-Omat AR films.
Quantification of fluorograms was carried out with an Epson GT-9000
scanner and Biometra ScanPack 2.0 software.
FACS analysis.
After being washed with DMEM
5 h
postinfection, CV-1 cells expressing viral protein were incubated
overnight at 32°C in DMEM+. They were then washed three times with
ice-cold PBS, removed from the dish by gentle scraping, and fixed with
paraformaldehyde (3% in PBS) for 1 h on ice. After three washes
with PBS containing 0.5% BSA, the cells were incubated with polyclonal
HA antibody (anti-influenza A virus rabbit serum, diluted 1:200 in
PBS-0.5% BSA) and then treated with a secondary antibody
(fluorescein-conjugated porcine immunoglobulin directed against rabbit
immunoglobulins, diluted 1:30). Unbound antibodies were washed out at
every step with PBS supplemented with 0.5% BSA. Finally the
antibody-cell complexes were suspended in PBS and analyzed with FACScan
equipment and Lysys II software (Becton Dickinson, Heidelberg,
Germany).
Labeling of RBCs with R18 and calcein-AM.
Human RBCs were
labeled with the lipid probe octadecyl rhodamine B chloride (R18) as
described previously (20, 21). A 10-µl sample of R18 (2 mM
in ethanol) was added to RBCs (1% hematocrit in 5 ml of PBS) under
vortexing. After the addition of 5 ml of PBS and incubation for 30 min
at room temperature in the dark, 20 ml of DMEM+ was added to the
suspension to absorb unbound probe. After further incubation at room
temperature in the dark for 20 min, the RBC suspension was washed five
times in 40 ml of PBS, and each wash was followed by centrifugation.
The last washing step was in PBS containing 1 mM CaCl2 and
1 mM MgCl2 (PBS++). The cells were kept in PBS++ at 4°C
for up to 48 h. The fluorescence intensity of intact labeled RBCs
due to R18 self-quenching was 25 to 30% of that of labeled RBCs
treated with 0.5% Triton X-100 (100% fluorescence because of infinite
dilution of R18). Double labeling was performed by the method of Morris
et al. (21) with slight modifications. Briefly, calcein-AM
(1 mM in dimethyl sulfoxide) was added to R18-labeled RBCs (10% in
PBS) to a final concentration of 20 µM. After incubation for 30 min
at 37°C in the dark, the RBC suspension was washed and further
incubated in PBS for 20 min at 37°C in the dark. The wash in PBS was
repeated twice, and doubly labeled RBCs were kept in PBS++ at room
temperature until use within 2 h.
Binding of fluorescently labeled RBCs to cells expressing viral
proteins.
After being washed with DMEM
5 h postinfection,
the cells were incubated overnight at 32°C in DMEM+, washed once with
DMEM (without serum), and incubated for 1 h at 37°C with 100 mU
of neuraminidase per ml in DMEM
. A 1-ml volume of labeled RBCs (0.2% hematocrit) in PBS++ was added to the monolayer and incubated for 15 min at room temperature in the dark with occasional gentle agitation.
Unbound RBCs were removed by five washes with PBS.
R18 fusion assay.
R18 RBC-acceptor cell complexes were
suspended by brief treatment (2 min at room temperature) with 100 µl
trypsin-EDTA solution (pretempered to 37°C), subjected to repeated
washings with PBS++ at 4°C, and placed on ice until further use.
At the beginning of each measurement, 30 µl of the R18-labeled
RBC-acceptor cell suspension was placed in a cuvette containing 1.97 ml
of prewarmed buffer (37°C) at the desired pH and kept stirred by a
magnetic Teflon-coated stirrer. FDQ of R18 was measured continuously by
using a spectrofluorimeter (SLM Aminco-Bowman, series 2) with 0.5-s
time resolution at excitation and emission wavelengths of 560 and 595 nm, respectively. A 570-nm cutoff filter was placed in the emission
optical pathway to reduce scattering. To normalize the data, the
percent FDQ (%FDQ) at any time point was calculated from the equation
%FDQ = 100[F(t)
F0]/(FT
F0), where F0 and
F(t) are fluorescence intensities at time 0 and
at a given time point t and FT is the
fluorescence intensity in the presence of 0.5% Triton X-100, defined
as the fluorescence at "infinite" dilution of the probe (20,
21).
Fluorescence microscopy.
After binding of doubly labeled
RBCs to acceptor cells, complexes on the dish were studied at room
temperature. By using the inverted microscope Axiovert 100 (Zeiss) with
a 40× objective (LD Achroplan; Zeiss), fusion was observed after PBS++
(pH 7.4) was replaced by NaAc++ (20 mM
NaC2H3O2 plus 150 mM NaCl
containing 1 mM CaCl2 and 1 mM MgCl2 [pH
5.0]). Calcein fluorescence was monitored with a "blue" filter set
(450- to 490-nm excitation filter, long-path 520-nm emission filter).
R18 fluorescence was visualized with a "green" filter set (510- to
560-nm excitation filter, long-path 590-nm emission filter).
Photomicrographs were taken with an MC 80 microscope camera (Zeiss) on
an Ektachrome EPH P1600x color reversal film for push processing
(Kodak) at 3,200 ASA.
Binding of RBCs to CV-1 cells by lectin and fusion assay.
Control experiments were performed to exclude fusion induction by
vaccinia virus proteins as follows. Cells expressing only vaccinia
virus proteins or, additionally wt HA were incubated for 5 min at room
temperature with 500 µl of WGA (8 µg/ml; Sigma) in PBS++, and 500 µl of labeled RBCs (0.2% hematocrit) was added. After further
incubation for 15 min at room temperature in the dark under occasional
gentle agitation, unbound RBCs were removed by five washes with PBS.
Fusion was monitored by fluorescence microscopy as described above.
 |
RESULTS |
Expression and characterization of HA and HA chimeras in
CV-1 cells.
wt HA and chimeric proteins were expressed in CV-1
cells with the vaccinia virus-T7 polymerase transient-expression
system.
In Table 1, the sequences of the TMRs and
of the CTs of both HA of influenza virus (subtype H7) and glycoprotein
F of Sendai virus, as well as the sequences of the peptide fragments
derived from the cytoplasmic proteins neurofibromin (NF78) and c-Raf-1 (Raf81), are shown. These peptides were chimerically combined with HA,
replacing its cytoplasmic domain. HF is a combination of the complete
transmembrane domain of HA and a short part of the TMR of F (see
Materials and Methods). In Table 1, all the studied proteins are shown
with their respective chimeric composition and designation.
The results of labeling experiments with
[35S]cysteine/methionine indicate that all proteins were
expressed at comparable levels to wt HA (H/H/H) except for H/H/F, which
was expressed at a slightly lower level, and cleaved into two subunits
irrespective of their composition in the TMR or CT (Fig.
1). Further control experiments included
a cross-linking study with dithio-bis(succinimidylpropionate), glycosidase treatment, and assessment of surface expression by cytometric analysis. The results demonstrated that all protein species
were expressed as trimers, which were processed properly during
biosynthetic glycosylation (data not shown). Interestingly all chimeras
were palmitoylated, although the acylation efficiency differed between
constructs (24, 28). Flow cytometry measurements revealed
that the chimeras were expressed with a lower transfection efficiency
than was wt HA, except for H/F/H and H/F/F, which reached about the
same efficiency level as H/H/H. The cell surface expression of the
chimeras was lower than that of wt HA, with the surface density of
H/F/H reaching about 73% of that of H/H/H indicated by the calculated
relative mean fluorescence index (Fig. 2; Table 2).

View larger version (46K):
[in this window]
[in a new window]
|
FIG. 1.
Expression of HA and HA-derived chimeras in CV-1 cells.
CV-1 transfected with wt HA (H/H/H), H/H/F, H/F/H, H/F/F, and H/HF/F
(left gel) or with vaccinia virus (VAC), H/H/H, H/H/N, and H/H/R (right
gel) were labeled with [35S]methionine/cysteine. Cell
extracts were immunoprecipitated with antibody against influenza virus
and subjected to SDS-PAGE (12% polyacrylamide gel) followed by
fluorography (1 day). The positions of uncleaved HA0 and
its two subunits, HA1 and HA2, in the gel are
marked on the left.
|
|

View larger version (32K):
[in this window]
[in a new window]
|
FIG. 2.
Histograms of the FACS analysis of CV-1 cells. The cells
cultured in 35-mm dishes were infected with vTF7-3 vaccinia virus and
transfected with plasmids encoding the respective protein as
designated. After being labeled with fluorescent antibodies, the cells
were treated as described in Materials and Methods and analyzed by
FACS. VAC represents CV-1 cells infected with wt vaccinia virus
(control); H/H/H, H/H/F, H/HF/F, H/F/F, H/F/H, H/H/N, and H/H/R
represent for cells transfected with the respective constructs. Cell
numbers (Counts) are plotted against fluorescence intensity
(FL1-Height). About 50,000 were analyzed in each experiment, except for
the H/F/F and H/F/H experiments in which about 20,000 cells were
measured. The calculated transfection efficiency and mean fluorescence
index are shown in Table 2.
|
|
Fusion of HA-expressing CV-1 cells with labeled RBCs.
To probe
for functional differences between HA wt and chimeric constructs, we
measured low-pH-triggered fusion of CV-1 cells expressing the different
HA-derived chimeras with human RBCs labeled with the lipidic
fluorophore R18 as well as the small water-soluble dye calcein. The
doubly labeled RBCs were efficiently bound to H/H/H as well as to the
chimeric constructs at neutral pH (Fig. 3). The differences in the extent of RBC
binding are probably due to the different surface expression levels
(Fig. 2). Since RBC binding corresponds to the amounts of protein
present on the surface, the structural differences in the TMRs and CTs
of the constructs had no specific influence on the capacity of the RBC binding. At room temperature (25°C) within 3 to 4 min after lowering the pH by replacing neutral buffer (pH 7.4) with acidic buffer (pH
5.0), we could observe the emergence of membrane-bound fluorescent dye
(R18) in the plasma membrane of the CV-1 cells. This indicates the
occurrence of membrane mixing, i.e., membrane fusion (see also Fig. 5
through 7). A parallel flow of calcein from the lumen of the RBCs into
the cytoplasm of the CV-1 cells expressing the above proteins could be
observed within 3 to 5 min after pH lowering, thus indicating the
formation of an aqueous continuity, i.e., fusion pore, between the RBC
and CV-1 cell (Fig. 3 and 4).

View larger version (91K):
[in this window]
[in a new window]
|
FIG. 3.
Fluorographs of doubly labeled RBCs bound to CV-1 cells
expressing chimeric or wt HA proteins. Chimeric proteins mediate
membrane mixing as well as cytoplasmic content mixing, as demonstrated
by fluorescence microscopy. Doubly labeled (R18 and calcein) human RBCs
were bound to monkey kidney cells expressing the respective protein as
described in Materials and Methods. At 4 min after the pH was reduced
to 5.0, R18 label was present in the membranes of the CV-1 cells,
indicating the mixing of membrane lipids. The flow of calcein from the
lumen of the bound RBCs into the cytoplasm of the CV-1 cells was
observed as well. This reveals that pores which permit the transfer of
aqueous compounds with a low molecular weight have been formed. All
observations were taken at room temperature. (Top row) R18 fluorescence
at pH 7.4; (second row) calcein fluorescence at pH 7.4; (third row) R18
fluorescence 4 min after the pH was reduced to 5.0; (bottom row)
calcein fluorescence 4 min after the pH was reduced to 5.0; (left
column) H/H/H; (second column) H/H/F; (third column) H/F/H; (right
column) H/F/F.
|
|

View larger version (92K):
[in this window]
[in a new window]
|
FIG. 4.
Fluorographs of doubly labeled RBCs bound to CV-1 cells
expressing H/H/N or H/H/R proteins. Doubly labeled (R18 and calcein)
human RBCs were bound to monkey kidney cells expressing H/H/N or H/H/R
constructs at pH 7.4 (not shown). At 6 min after the pH was reduced to
5.0, R18 label was present in the membranes of the CV-1 cells,
indicating the mixing of the membrane lipids. The flow of calcein from
the lumen of the bound RBC into the cytoplasm of the CV-1 cell was
observed as well. This reveals that pores which permit the transfer of
aqueous compounds with low molecular weights have been formed. The
experiments were performed at room temperature. (Top row) R18
fluorescence 6 min after the pH was reduced to 5.0; (bottom row)
calcein fluorescence 6 min after the pH was reduced to 5.0; (left
column) H/H/N; (right column) H/H/R.
|
|
wt H/H/H, as well as all the studied chimeric constructs, H/H/F,
H/HF/F, H/F/H, H/F/F, H/H/N, and H/H/R, displayed the same functional
characteristics. At low pH, all of them were able to mediate
redistribution of the lipidic dye R18 between the plasma membranes of
the RBC-CV-1 cell complexes as well as the flow of the aqueous dye
calcein from the lumen of labeled human RBCs into the cytoplasm of
unlabeled CV-1 cells expressing the respective protein.
In numerous sets of repeat experiments to measure membrane and
cytoplasmic mixing, we have observed some differences in the time
course of label redistribution which were probably caused by variations
of the protein concentration in the cell membrane between different
transfections. It has been shown that the density of HA molecules in
the plasma membrane considerably influences the lag time (time between
triggering and onset) as well as the initial rate (highest rate of
fluorescence increase after onset) of membrane fusion mediated by
influenza virus HA (5, 18).
Kinetics of membrane fusion.
Since no difference between the
fusogenicity of the various proteins was apparent from these
microscopic studies, we also compared the kinetics of membrane fusion
induced by chimeras with that of wt HA at various pHs. In Fig.
5, the typical kinetics are shown for wt
HA (H/H/H) and the chimeric constructs between HA and F at pH 4.8, 5.8, and 6.7 and 37°C. For all the proteins, no significant increase of
R18 fluorescence intensity was observed after the addition of RBC-CV-1
cell complexes to the buffer set to pH 6.7 (Fig. 5). On the other hand,
immediately after addition of the RBC-CV-1 cell complexes to the
buffer set to pH 4.8, a steep increase of R18 fluorescence intensity,
reaching a plateau after about 100 s, was observed (Fig. 5).
Measurements at an intermediate pH value (pH 5.8) resulted in a slower
increase of the R18 fluorescence for all the studied proteins (Fig. 5).
We observed similar time courses of FDQ for H/H/N and H/H/R, as shown
for pH 5.0 in Fig. 6. For both
constructs, we observed a smaller fusion extent, and in some
preparations we found a tendency for slower lipid mixing. The
fluorescence increase is caused by the relief of R18 self-quenching due
to redistribution of the lipid-like fluorophore between the RBC and
CV-1 cell membrane upon fusion of plasma membranes. The normalized data
show that in all cases fusion activity was established with about the
same kinetics but with some differences in the extents, most probably
due to the different expression levels, in particular for H/H/N and
H/H/R (Fig. 2; Table 2).

View larger version (66K):
[in this window]
[in a new window]
|
FIG. 5.
Kinetics of FDQ of R18-labeled RBCs bound to transfected
CV-1 cells at different pHs. Typical time courses of the fusion of CV-1
cells expressing H/H/H or the H/F chimeric constructs with R18-labeled
human RBCs at 37°C are shown. The cell-RBC suspension was added to
the buffer in the cuvette at the respective pHs as indicated, and
fusion monitoring started immediately (t = 0). At
t = 590 s, Triton X-100 was added for infinite
dilution of the fluorophore. The kinetics were normalized as described
by Morris et al. (20). The fluorescence intensity at pH 7.4 was set to 0%, and fluorescence intensity after the addition of Triton
X-100 was set to 100% FDQ (for details, see Materials and Methods).
The results of two independent experiments with wt HA (H/H/H) are
presented to show the experimental variability.
|
|

View larger version (49K):
[in this window]
[in a new window]
|
FIG. 6.
Kinetics of the FDQ of R18-labeled RBCs bound to H/H/N-
and H/H/R-transfected CV-1 cells at different pHs. Typical time courses
of fusion of CV-1-cells expressing H/H/N and H/H/R chimeric constructs
with R18-labeled human RBCs at 37°C are shown. The experimental
procedures were the same as those described for Fig. 5 (note the
different scaling). Curve A, H/H/N at pH 5.0; curve B, H/H/R at pH 5.0;
curve C, H/H/N and H/H/R at pH 6.7.
|
|
The rapid FDQ observed can not be attributed to a nonspecific exchange
of R18 between the membranes of human RBCs and CV-1 cells, since only a
slow fluorescence increase was observed at pH 4.8 with noninfected
monkey kidney cells which had R18-labeled RBCs bound via the exogenous
lectin WGA (data not shown). Neither solitary R18-labeled RBCs at pH
4.8 nor complexes of RBCs and HA-expressing cells at neutral pH showed
any significant FDQ. Furthermore, only a slight increase in the R18
fluorescence could be observed with R18-labeled RBCs bound by WGA to
vaccinia virus-infected CV-1 cells, which excludes the potential
contribution of vaccinia virus peptides to fusion (see Fig. 7B, inset).
Since other control experiments exclude a possible inhibition of fusion
by WGA in the medium, all the above observed R18 FDQ has to be
attributed to the HA or chimera-induced mixing of the labeled RBC
membrane and the unlabeled CV-1 plasma membrane.
Figure 7 shows the pH dependence of FDQ.
It becomes apparent that fusion induced by wt HA and that induced by
chimeric constructs follow similar pH profiles. Under no instance was
FDQ at pH values above 6.5 observed. The rather broad pH optimum of
fusion coincides with that of the wt virus (H7), as shown previously
(27). We have no indication of a substantial shift in the pH
optima of fusion as has been reported very recently for mutants of HA
from influenza virus X31 (H3) (16). Controls with wt
vaccinia virus (no HA protein involved) showed only a slight pH
dependence, close to the background levels of the fluorescence
intensity (Fig. 7B, inset).

View larger version (22K):
[in this window]
[in a new window]
|
FIG. 7.
pH dependence of the maximal FDQ of R18-labeled
erythrocytes bound to CV-1 cells expressing foreign protein. The
kinetics of the FDQ of R18 at different pH values were recorded and
normalized as described for Fig. 5. For each studied protein, the
maximal FDQ values before the addition of Triton X-100 are plotted
against the respective pH values. The inserted graph vac-control in
panel B represents the control with CV-1 cells infected by vaccinia
virus without any foreign DNA. For this measurement, labeled RBCs were
bound to CV-1 cells via WGA. For all probes except the vac-control, the
FDQ values were normalized to the respective FDQ maximum of the pH
dependence. The maximal FDQ ranged between 30 and 60%.
|
|
 |
DISCUSSION |
The use of chimeric constructs offers the opportunity to search
for dependencies of protein-induced membrane fusion on specific amino
acid sequences and properties of the transmembrane and/or cytoplasmic
domain of the fusion protein. We have constructed chimeras of the
well-characterized fusion protein of influenza virus, HA, with distinct
alterations in its membrane-spanning and cytoplasmic domain, and
studied the fusion properties after expression. The domains in question
were replaced in a combinatorial fashion by the respective parts of the
fusion protein of Sendai virus, F. Although the two proteins are
related in their functions, the sequences and physical properties of
their transmembrane and cytoplasmic domains differ considerably (Table
1). In addition, we studied two HA chimeras which contained peptides
derived from totally unrelated soluble cytoplasmic proteins as their
cytoplasmic domains of HA. wt HA and all constructs were expressed on
the plasma membrane of the transfected CV-1 cells as trimers and showed the appropriate posttranslational modifications. Serious differences were observed only in the degree of palmitoylation. However, reports from other groups and our previous studies had shown that this hydrophobic modification has no major effect on either membrane fusion
or formation of an aqueous fusion pore mediated by influenza virus HA
(13, 27). Thus, the constructed chimeras were suitable for
studying the potential contribution of the particular domains in
question on fusion induction competence in comparison to that of wt HA.
The fusion activity of the presented constructs and wt HA (designated
H/H/H) were studied by using fluorescently labeled human RBCs. After
the pH of the surrounding medium was reduced from 7.4 to 5.0, all our
expression products induced the merging of the unlabeled HA-bearing
plasma membrane of CV-1 cells with R18-labeled membranes of human RBCs
with a similar time course (Fig. 3, 5, and 6). Furthermore, the
fluorescence label calcein redistributed into the lumen of the
transfected CV-1 cells after the pH of the surrounding medium was
reduced, no matter which of the proteins was expressed. As observed for
membrane mixing, the time course of the cytoplasmic mixing triggered by
the chimeras was comparable to that induced by wt HA (Fig. 3 and 4),
showing that all the chimeric constructs used in this study were able
to induce both membrane mixing and formation of an aqueous fusion pore,
allowing free movement of cytoplasmic water-soluble molecules as
calcein. Thus, for both of these events, the influenza virus HA
requires neither its own specific transmembrane and cytoplasmic domain sequences nor any particular length of its CT. It has been reported that a GPI anchor is not sufficient for promoting the formation of
fusion pores (15), which indicates that at least the
membrane-spanning domain is required. On the other hand, our data
suggest that this is due not to a lack of specific transmembrane and/or
cytoplasmic amino acid sequences but probably to the complete deletion
of the TMR and CT in GPI-HA. The role of the CT in our system for fusion remains open. Recently, it has been shown for HA of another influenza virus subtype (H3) that this domain is not required for
membrane mixing and formation of a small aqueous pore (13).
Recent models of HA-mediated fusion emphasize the role of both domains,
in particular of the TMR, for the formation and widening of an aqueous
fusion pore (35, 38). One of these models describes a
lipidic "stalk" as an intermediate which is formed by merging of
the contacting outer monolayers of the fusing membranes, the so-called
hemifusion diaphragm (4, 38). Destabilization of this
diaphragm is necessary for the formation and widening of an aqueous
fusion pore as the successful completion of the fusion event. As
suggested by Melikyan et al. (17), it is probably the
mechanical coupling of the HA ectodomain to the TMR which causes such a
destabilization. The diaphragm can be also disturbed by enhancement of
the positive spontaneous curvature of the nonfused inner leaflets
(reviewed in reference 4). Whatever the detailed molecular mechanism is, our results imply that this mechanical coupling
does not require the specific sequence of TMR and CT of wt HA.
 |
ACKNOWLEDGMENTS |
This work was supported by grants from the Deutsche
Forschungsgemeinschaft to M.F.G.S. (SFB 366) and A.H. (SFB 312).
We are grateful to Wolf-Dietrich Döcke, Florian Kern, and Felix
Randow (Institute for Clinical Immunology, Charité, Berlin, Germany) for advice and use of their FACS facilities.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Institut
für Biologie/Biophysik, Mathematisch-Naturwissenschaftliche
Fakultät I, Humboldt-Universität zu Berlin,
Invalidenstrasse 43, D-10115 Berlin, Germany. Phone:
49-30-2093-8830. Fax: 49-30-2093-8585. E-mail:
Andreas=Herrmann{at}biologie.hu-berlin.de.
 |
REFERENCES |
| 1.
|
Bagai, S., and R. A. Lamb.
1995.
Quantitative measurement of paramyxovirus fusion: differences in requirements of glycoproteins between simian virus 5 and human parainfluenza virus 3 or Newcastle disease virus.
J. Virol.
69:6712-1719[Abstract].
|
| 2.
|
Bagai, S., and R. A. Lamb.
1996.
Truncation of the COOH-terminal region of the paramyxovirus SV5 fusion protein leads to hemifusion but not complete fusion.
J. Cell Biol.
135:73-84[Abstract/Free Full Text].
|
| 3.
|
Chakrabarti, L.,
M. Emerman,
P. Tiollais, and P. Sonigo.
1989.
The cytoplasmic domain of simian immunodeficiency virus transmembrane protein modulates infectivity.
J. Virol.
63:4395-4403[Abstract/Free Full Text].
|
| 4.
|
Chernomordik, L.,
M. M. Kozlov, and J. Zimmerberg.
1995.
Lipids in biological membrane fusion.
J. Membr. Biol.
146:1-14[Medline].
|
| 5.
|
Danieli, T.,
S. L. Pelletier,
Y. I. Henis, and J. M. White.
1996.
Membrane fusion mediated by influenza virus hemagglutinin requires the concerted action of at least three hemagglutinin trimers.
J. Cell Biol.
133:559-569[Abstract/Free Full Text].
|
| 6.
|
Dong, J.,
M. G. Roth, and E. Hunter.
1992.
A chimeric avian retrovirus containing the influenza virus hemagglutinin gene has an expanded host range.
J. Virol.
66:7374-7382[Abstract/Free Full Text].
|
| 7.
|
Dubay, J. W.,
S. J. Roberts,
B. H. Hahn, and E. Hunter.
1992.
Truncation of the human immunodeficiency virus type 1 transmembrane glycoprotein cytoplasmic domain blocks virus infectivity.
J. Virol.
66:6616-6625[Abstract/Free Full Text].
|
| 8.
|
Fridman, M.,
A. Tikoo,
M. Varga,
A. Murphy,
M. S. A. Nur-E-Kamal, and H. Maruta.
1994.
The minimal fragments of c-Raf-1 and NF1 that can suppress v-Ha-Ras-induced malignant phenotype.
J. Biol. Chem.
269:30105-30108[Abstract/Free Full Text].
|
| 9.
|
Fuerst, T. R.,
E. G. Niles,
F. W. Studier, and B. Moss.
1986.
Eucaryotic transient-expression system based on recombinant vaccinia virus the synthesizes bacteriophage T7 RNA polymerase.
Proc. Natl. Acad. Sci. USA
83:8122-8126[Abstract/Free Full Text].
|
| 10.
|
Helseth, E.,
U. Olshevsky,
D. Gabuzda,
B. Ardman,
W. Kaseltine, and J. Sodroski.
1990.
Changes in the transmembrane region of the human immunodeficiency virus type 1 gp41 envelope glycoprotein affect membrane fusion.
J. Virol.
64:6314-6318[Abstract/Free Full Text].
|
| 11.
|
Horton, R. M., and L. R. Pease.
1991.
Recombination and mutagenesis of DNA-sequences using PCR, p. 217-247. In
M. J. McPherson (ed.), Directed mutagenesis: a practical approach.
Oxford University Press, Oxford, United Kingdom.
|
| 12.
|
Jin, H.,
G. P. Leser, and R. A. Lamb.
1994.
The influenza virus hemagglutinin cytoplasmic tail is not essential for virus assembly or infectivity.
EMBO J.
13:5504-5515[Medline].
|
| 13.
|
Jin, H.,
K. Subbarao,
S. Bagai,
G. P. Leser,
B. R. Murphy, and R. A. Lamb.
1996.
Palmitoylation of the influenza virus hemagglutinin (H3) is not essential for virus assembly or infectivity.
J. Virol.
70:1406-1414[Abstract].
|
| 14.
|
Jin, H.,
G. P. Leser,
J. Zhang, and R. A. Lamb.
1997.
Influenza virus hemagglutinin and neuraminidase cytoplasmic tails control particle shape.
EMBO J.
16:1236-1247[Medline].
|
| 15.
|
Kemble, G. W.,
T. Danieli, and J. M. White.
1994.
Lipid-anchored influenza hemagglutinin promotes hemifusion, not complete fusion.
Cell
76:383-390[Medline].
|
| 16.
|
Lin, Y. P.,
S. A. Wharton,
J. Martín,
J. J. Skehel,
D. C. Wiley, and D. A. Steinhauer.
1997.
Adaptation of egg-grown and transfectant influenza viruses for growth in mammalian cells: selection of hemagglutinin mutants with elevated pH of membrane fusion.
Virology
233:402-410[Medline].
|
| 17.
|
Melikyan, G. B.,
J. M. White, and F. S. Cohen.
1995.
GPI-anchored influenza hemagglutinin induces hemifusion to both red blood cells and planar bilayer membranes.
J. Cell Biol.
131:679-691[Abstract/Free Full Text].
|
| 18.
|
Melikyan, G. B.,
W. D. Niles, and F. S. Cohen.
1995.
The fusion kinetics of influenza hemagglutinin expressing cells to planar lipid bilayer membranes is affected by HA density and host cell surface.
J. Gen. Physiol.
106:783-802[Abstract/Free Full Text].
|
| 19.
|
Melikyan, G. B.,
S. A. Brener,
D. C. Ok, and F. S. Cohen.
1997.
Inner but not outer membrane leaflets control the transition from glycosylphosphatidylinositol-anchored influenza hemagglutinin-induced hemifusion to full fusion.
J. Cell Biol.
136:995-1005[Abstract/Free Full Text].
|
| 20.
|
Morris, S. J.,
D. P. Sarkar,
J. M. White, and R. Blumenthal.
1989.
Kinetics of pH-dependent fusion between 3T3 fibroblasts expressing influenza hemagglutinin and red blood cells.
J. Biol. Chem.
264:3972-3978[Abstract/Free Full Text].
|
| 21.
|
Morris, S. J.,
J. Zimmerberg,
D. P. Sarkar, and R. Blumenthal.
1993.
Kinetics of cell fusion mediated by viral spike glycoproteins.
Methods Enzymol.
221:42-58[Medline].
|
| 22.
|
Moss, B.,
O. Elroy-Stein,
T. Mizukamu,
W. A. Alexander, and T. R. Fuerst.
1990.
Product review. New mammalian expression vectors.
Nature
348:91-92[Medline].
|
| 23.
|
Nur-E-Kamal, M. S. A.,
M. Varga, and H. Maruta.
1993.
The GTPase-activating NF1 fragment of 91 amino acids reverses v-Ha-Ras-induced malignant phenotype.
J. Biol. Chem.
268:22331-22337[Abstract/Free Full Text].
|
| 24.
|
Nur-E-Kamal, M. S. A.,
H. Reverey,
E. Ponimaskin,
B. Schroth-Diez,
A. Herrmann, and M. F. G. Schmidt.
1997.
Target delivery of human neurofibromin and c-Raf-1 mutants to the cytoplasmic membrane by use of the influenza virus hemagglutinin.
Biochim. Biophys. Acta
1338:233-243[Medline].
|
| 25.
| Nüssler, F., M. Clague, and A. Herrmann.
Characterization of hemifusion intermediate induced by GPI-anchored
hemagglutinin: meta-stability of the hemifusion intermediate. Biophys.
J., in press.
|
| 26.
|
Owens, R. J.,
C. Burke, and J. K. Rose.
1994.
Mutations in the membrane-spanning domain of the human immunodeficiency virus envelope glycoprotein that affect fusion activity.
J. Virol.
68:570-574[Abstract/Free Full Text].
|
| 27.
|
Philipp, H. C.,
B. Schroth,
M. Veit,
M. Krumbiegel,
A. Herrmann, and M. F. G. Schmidt.
1995.
Assessment of fusogenic properties of influenza virus hemagglutinin by site-directed mutagenesis and hydroxylamine treatment.
Virology
210:20-28[Medline].
|
| 28.
| Ponimaskin, E., and M. F. G. Schmidt.
Changes of transmembrane and cytoplasmic tail domains modulate
palmitoylation of proteins. Submitted for publication.
|
| 29.
|
Ritter, G. D.,
M. J. Mulligan,
S. L. Lydy, and R. W. Compans.
1993.
Cell fusion activity of the simian immunodeficiency virus envelope protein is modulated by the intracellular domain.
Virology
197:255-264[Medline].
|
| 30.
|
Roth, M. G.,
C. Doyle,
J. Sambrook, and M.-J. Gething.
1986.
Heterologous transmembrane and cytoplasmic domains direct functional chimeric influenza virus hemagglutinins into the endocytic pathway.
J. Cell Biol.
102:1271-1283[Abstract/Free Full Text].
|
| 31.
|
Sambrook, J.,
E. Fritsch, and T. Maniatis.
1989.
.
Molecular cloning: a laboratory manual, 2nd ed.
Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
|
| 32.
|
Simpson, D. A., and R. A. Lamb.
1992.
Alterations to influenza virus hemagglutinin cytoplasmic tail modulate virus infectivity.
J. Virol.
66:790-803[Abstract/Free Full Text].
|
| 33.
|
Skehel, J. J.,
P. M. Bayley,
E. B. Brown,
S. R. Martin,
M. D. Waterfield,
J. M. White,
I. A. Wilson, and D. C. Wiley.
1982.
Changes in conformation of influenza virus hemagglutinin at the pH optimum of virus-mediated membrane fusion.
Proc. Natl. Acad. Sci. USA
79:968-972[Abstract/Free Full Text].
|
| 34.
|
Spies, C. P., and R. W. Compans.
1994.
Effects of cytoplasmic domain length on the cell surface expression and syncytium forming capacity of the simian immunodeficiency virus envelope glycoprotein.
Virology
203:8-19[Medline].
|
| 35.
|
White, J. M.
1995.
Membrane fusion: the influenza paradigm.
Cold Spring Harbor Symp. Quant. Biol.
60:581-588[Medline].
|
| 36.
|
White, J. M., and I. A. Wilson.
1987.
Anti-peptide antibodies detect steps in a protein conformational change: low-pH activation of the influenza virus hemagglutinin.
J. Cell Biol.
105:2887-2896[Abstract/Free Full Text].
|
| 37.
|
Yao, Q., and R. W. Compans.
1995.
Differences in the role of the cytoplasmic domain of the human parainfluenza virus fusion proteins.
J. Virol.
69:7045-7053[Abstract].
|
| 38.
|
Zimmerberg, J.,
S. S. Vogel,
T. Whalley,
I. Plonsky,
A. Sokoloff,
A. Chanturia, and L. V. Chernomordik.
1995.
Intermediates in membrane fusion.
Cold Spring Harbor Symp. Quant. Biol.
60:589-599[Medline].
|
J Virol, January 1998, p. 133-141, Vol. 72, No. 1
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Ujike, M., Nakajima, K., Nobusawa, E.
(2006). A point mutation at the C terminus of the cytoplasmic domain of influenza B virus haemagglutinin inhibits syncytium formation. J. Gen. Virol.
87: 1669-1676
[Abstract]
[Full Text]
-
Shmulevitz, M., Salsman, J., Duncan, R.
(2003). Palmitoylation, Membrane-Proximal Basic Residues, and Transmembrane Glycine Residues in the Reovirus p10 Protein Are Essential for Syncytium Formation. J. Virol.
77: 9769-9779
[Abstract]
[Full Text]
-
Maresova, L., Pasieka, T. J., Grose, C.
(2001). Varicella-Zoster Virus gB and gE Coexpression, but Not gB or gE Alone, Leads to Abundant Fusion and Syncytium Formation Equivalent to Those from gH and gL Coexpression. J. Virol.
75: 9483-9492
[Abstract]
[Full Text]
-
Armstrong, R. T., Kushnir, A. S., White, J. M.
(2000). The Transmembrane Domain of Influenza Hemagglutinin Exhibits a Stringent Length Requirement to Support the Hemifusion to Fusion Transition. J. Cell Biol.
151: 425-438
[Abstract]
[Full Text]
-
Kozerski, C., Ponimaskin, E., Schroth-Diez, B., Schmidt, M. F. G., Herrmann, A.
(2000). Modification of the Cytoplasmic Domain of Influenza Virus Hemagglutinin Affects Enlargement of the Fusion Pore. J. Virol.
74: 7529-7537
[Abstract]
[Full Text]
-
Markosyan, R. M., Cohen, F. S., Melikyan, G. B.
(2000). The Lipid-anchored Ectodomain of Influenza Virus Hemagglutinin (GPI-HA) Is Capable of Inducing Nonenlarging Fusion Pores. Mol. Biol. Cell
11: 1143-1152
[Abstract]
[Full Text]
-
Melikyan, G. B., Lin, S., Roth, M. G., Cohen, F. S.
(1999). Amino Acid Sequence Requirements of the Transmembrane and Cytoplasmic Domains of Influenza Virus Hemagglutinin for Viable Membrane Fusion. Mol. Biol. Cell
10: 1821-1836
[Abstract]
[Full Text]